Biologics News

WAILEA, Hawaii — In this video from Orthopedics Today Hawaii 2021, John M. Tokish, MD, spoke about the emerging use of biologics and advances in the treatment of shoulder instability and bone loss.

WAILEA, Hawaii — In this video from Orthopedics Today Hawaii 2021, Jack M. Bert, MD, spoke about the use of biologics in the treatment of knee osteoarthritis.

Published results showed younger age and high cell concentration in bone marrow aspirate may positively impact connective tissue progenitor prevalence and concentration.

Use of a stem cell-based articular regeneration technology may be safe and effective in the treatment of large knee cartilage defects, according to a presenter.

Published results showed a single intra-articular injection of microfat with or without platelet-rich plasma may be safe and offer significant clinical improvement among patients with knee osteoarthritis.

Treatment with biologic injections may lead to serious complications, such as infections requiring multiple surgical procedures and inflammatory reactions, according to published results.

Intra-articular injections of mesenchymal stem cells into the synovium may yield expression of a number of genes that inhibit progression of osteoarthritis, according to a speaker at the 2021 OARSI World Congress virtual meeting.

Understanding the complex associations between pain, function and structural factors in the joints may allow clinicians to use intraarticular injections more effectively in osteoarthritis, according to a speaker at the 2021 OARSI World Congress.

Platelet-rich plasma and concentrated bone marrow aspirate injections had similar outcomes for treatment of knee osteoarthritis at 24-month follow-up, according to results.

The FDA cleared an investigational new drug application for NVD-003, a stem cell therapy for treatment of children with congenital pseudarthrosis of the tibia, according to the agent’s manufacturer.